Francesco Ferrara | Pharmacist | Innovative Research Award

Innovative Research Award

Francesco Ferrara – ASL Napoli 3 SUD, Italy
Francesco Ferrara
AffiliationASL Napoli 3 SUD
CountryItaly
Scopus ID59464334600
Documents1546
Citations2176
h-index27
Subject AreaPharmacist
EventInternational Research Awards
ORCID0000-0001-9298-6783

Francesco Ferrara is an Italian hospital pharmacist and researcher affiliated with ASL Napoli 3 SUD. His academic profile demonstrates extensive contributions to pharmacology, clinical pharmacy, healthcare governance, and therapeutic innovation. Through a substantial publication record and active international collaboration, he has contributed to evidence-based healthcare practices and multidisciplinary medical research.[1]

Abstract

This article evaluates the scholarly profile of Francesco Ferrara in relation to the Innovative Research Award. His research activities encompass pharmacology, healthcare management, antimicrobial resistance, chronic disease treatment, and pharmaceutical policy. The combination of publication productivity, citation influence, and interdisciplinary engagement highlights a sustained commitment to advancing healthcare knowledge and clinical practice.[1]

Keywords

Pharmacology, Clinical Pharmacy, Healthcare Governance, Drug Policy, Therapeutic Innovation, Antimicrobial Resistance, Pharmaceutical Research.

Introduction

Modern healthcare requires researchers capable of integrating clinical evidence, pharmaceutical management, and public health priorities. Francesco Ferrara has developed a multidisciplinary portfolio addressing therapeutic effectiveness, healthcare sustainability, and emerging treatment strategies. His work reflects contemporary priorities in patient-centered care and pharmaceutical innovation.[2]

Research Profile

Ferrara serves within the Italian Health Service and has accumulated professional experience across multiple healthcare institutions. His expertise includes clinical pharmacy, pharmacoeconomics, healthcare technology assessment, and pharmaceutical governance. The researcher maintains active participation in scientific publishing and peer-review activities across internationally recognized journals.[1]

Research Contributions

Key contributions include investigations into antimicrobial resistance, biosimilar medicines, chronic disease management, neurological disorders, dermatological therapies, and healthcare expenditure analysis. His research frequently combines clinical relevance with policy implications, supporting informed decision-making in healthcare systems and pharmaceutical practice.[3]

Publications

Publications

Francesco Ferrara has authored and co-authored an extensive portfolio of scholarly publications spanning pharmacology, clinical pharmacy, antimicrobial resistance, chronic disease management, dermatology, neurology, cardiovascular medicine, and healthcare governance. His research has appeared in internationally recognized journals including Inflammopharmacology, European Journal of Clinical Pharmacology, Pharmaceuticals, Antibodies, and Hospital Pharmacy. Through collaborations with multidisciplinary research teams, he has contributed to studies addressing therapeutic innovation, drug utilization, public health challenges, and evidence-based healthcare policies. The breadth and consistency of his publication record demonstrate sustained scientific productivity and a commitment to advancing pharmaceutical and clinical research across diverse healthcare settings.[2][3]

Research Impact

With more than two thousand citations and a substantial h-index, Ferrara’s scholarly output demonstrates measurable academic influence. His studies contribute to clinical practice, healthcare policy development, and pharmaceutical governance. The broad thematic coverage of his work illustrates a capacity to address both specialized and system-level healthcare challenges.[1]

Award Suitability

The Innovative Research Award recognizes individuals who demonstrate originality, sustained scholarly productivity, and meaningful research outcomes. Ferrara’s record of publications, international collaborations, and healthcare-focused investigations aligns with these criteria. His contributions support innovation in pharmacological science and evidence-based healthcare management.[4]

Conclusion

Francesco Ferrara has established a notable academic profile through sustained research activity, clinical expertise, and interdisciplinary collaboration. His contributions to pharmacology and healthcare policy provide practical and scholarly value. These achievements support his recognition as a strong candidate for the Innovative Research Award.[5]

References

    1. ORCID. (2026). Francesco Ferrara (ORCID iD: 0000-0001-9298-6783). ORCID Registry.
      https://orcid.org/0000-0001-9298-6783
    2. Ferrara, F., De Berardinis, F., Scognamiglio, M., & Zovi, A. (2026). The shifting paradigm of monoclonal antibodies in COVID-19 management: From early triumphs to viral resistance and future perspectives. Antibodies, 15(3), Article 48.
      https://doi.org/10.3390/antib15030048
    3. Ferrara, F. (2026). Therapeutic update on alopecia areata: A critical review of standard and emerging targeted therapies. Inflammopharmacology.
      https://doi.org/10.1007/s10787-026-02273-8
    4. Ferrara, F., Martellone, L., Vaccaro, M., Coluccia, A., Scognamiglio, M., Langella, R., Zovi, A., & Polito, G. (2025). Real-life impact of cefiderocol in carbapenem-resistant Acinetobacter baumannii infections (CRAb): A narrative review. European Journal of Clinical Pharmacology.
      https://doi.org/10.1007/s00228-025-03866-y
    5. Elsevier. (2026). Scopus Author Profile: Francesco Ferrara (Author ID: 59464334600). Scopus Preview.
      https://www.scopus.com/authid/detail.uri?authorId=59464334600

Michal Galek-Aldridge | Health Sciences | Best Scholar Award

Mr. Michal Galek-Aldridge | Health Sciences | Best Scholar Award

University Medical Center Utrecht | Netherland

Michał Gałek-Aldridge is a multilingual medical researcher and physician with a strong interdisciplinary background bridging molecular science, engineering, and regenerative medicine. Born on September 18, 1993, in Tucson, Arizona, he holds Polish nationality and is fluent in English, Dutch, Polish, and Russian, with advanced proficiency in French and beginner-level Portuguese. Michał’s academic journey spans multiple international institutions, including The British School of Warsaw, the Anglo-American School in Moscow, and the International School of Amsterdam, culminating in an International Baccalaureate (IB) bilingual diploma in 2011. He pursued a Bachelor of Science in Molecular Science and Technology at Delft University of Technology and Leiden University, completing his thesis on “The loading of chemotherapeutics in polymersome carriers” at the Reactor Institute Delft. During this period, Michał received an Erasmus Mundus scholarship to study at Chalmers University in Sweden, where he expanded his expertise in nuclear chemistry, project management, waste management, and ecology. Driven by a passion for medicine, he subsequently earned both a Bachelor and Master of Science in Medicine at the University of Amsterdam, with clinical experience in orthopedic surgery at the UMC Amsterdam. Since 2021, Michał has been a PhD candidate at the University Medical Center Utrecht, focusing on the translation of regenerative surgical shoulder implants into clinical practice. His research integrates advanced therapies, 3D-printed medical devices, and regenerative medicine, while also addressing regulatory compliance, intellectual property assessment, and GMP evaluation for ATMP production. He actively supervises students at the 3D Lab, contributing to both academic and translational research. His work is supported by prominent supervisors including Prof. Michel van den Bekerom, Dr. Arthur van Noort, Dr. Bart van der Wal, and Prof. Jos Malda. Michał has contributed extensively to the scientific literature, publishing as first author on innovative orthopedic treatments and as co-author in high-impact journals, including The Lancet Respiratory Medicine, Journal of Shoulder and Elbow Surgery, and JSES Reviews, Reports & Techniques. His research has spanned topics from patient-specific bone regenerative implants and congenital hip dislocation management to COVID-19 respiratory subphenotypes and ventilation strategies. Michał’s professional development is complemented by diverse certifications and conferences, including Medical Device Regulation (EU MDR 2018), ISO 13485, 3D printing in hospitals, and arthroscopy and arthroplasty courses. Outside of his professional endeavors, he maintains an active lifestyle through kickboxing, Muay Thai, skiing, kite surfing, and cooking. His combination of scientific rigor, clinical expertise, and entrepreneurial initiative positions him as a rising leader in regenerative medicine and medical innovation.

Profile: Scopus

Featured Publications

van Spanning, S. H., van Iersel, T. P., Verweij, L. P. E., van Noort, A., Floor, S., Galek-Aldridge, M., van den Borne, M. P. J., Kleinlugtenbelt, Y. V., van den Bekerom, M. P. J., & van Deurzen, D. F. P. (2025). Lower education level is associated with failure to return to sport whereas bony Bankart lesions predict successful return to preinjury sport level after open Latarjet procedure. Arthroscopy: The Journal of Arthroscopic & Related Surgery. Advance online publication.